Outlook Therapeutics
OTLK
OTLK
64 hedge funds and large institutions have $62.7M invested in Outlook Therapeutics in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
21.77% less ownership
Funds ownership: 58.05% → 36.28% (-22%)
30% less capital invested
Capital invested by funds: $89.9M → $62.7M (-$27.2M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
64
Holding in Top 10
–
Calls
$99K
Puts
$7K
Top Buyers
| 1 | +$3.7M | |
| 2 | +$1.84M | |
| 3 | +$1.63M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.52M |
| 5 |
BlackRock
New York
|
+$1.18M |
Top Sellers
| 1 | -$8.53M | |
| 2 | -$1.87M | |
| 3 | -$341K | |
| 4 |
Millennium Management
New York
|
-$331K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$327K |